Angene Chemical
Draw
|
Currency :
Home Products

AG00IA2I

56420-45-2 | (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

Chemical structure of (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione, CAS 56420-45-2
AG00IA2I
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 56420-45-2
Catalog Number AG00IA2I(AGN-PC-0SLM1R)
Chemical Name (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
IUPAC Name (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
InChI InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1
InChI Key AOJJSUZBOXZQNB-VTZDEGQISA-N
MDL Number MFCD00274554
Molecular Formula C27H29NO11
Molecular Weight 543.5193
SMILES N[C@H]1C[C@@H](O[C@H]([C@@H]1O)C)O[C@H]1C[C@@](CC=2C(=C3C(C=4C=CC=C(C4C(C3=C(C12)O)=O)OC)=O)O)(C(CO)=O)O
UNII 3Z8479ZZ5X
Synonyms
4' Epi Adriamycin, 4' Epi Doxorubicin, 4' Epi DXR, 4' Epiadriamycin, 4' Epidoxorubicin, 4'-Epi-Adriamycin, 4'-Epi-Doxorubicin, 4'-Epi-DXR, 4'-Epiadriamycin, 4'-Epidoxorubicin, Ellence, EPI cell, EPI-cell, EPIcell, Epilem, Epirubicin, Epirubicin Hydrochloride, Farmorubicin, Farmorubicina, Farmorubicine, Hydrochloride, Epirubicin, IMI 28, IMI-28, IMI28, NSC 256942, NSC-256942, NSC256942, Pharmorubicin, Epirubicin, 56420-45-2, Epiadriamycin, Epidoxorubicin, 4'-Epiadriamycin, Ellence, 4'-epidoxorubicin, Epirubicina, Epirubicine, Epirubicinum, Pidorubicina, Pidorubicine, Pidorubicinum, Ridorubicin, Epi-DX, Epirubicine [French], Epirubicinum [Latin], 4-Epidoxorubicin, Epirubicina [Spanish], IMI 28, Epirubicine [INN-French], Epirubicinum [INN-Latin], Epirubicina [INN-Spanish], Pidorubicine [INN-French], Pidorubicinum [INN-Latin], Pidorubicina [INN-Spanish], Epirubicin [INN:BAN], Farmorubicin, 4'-epi-Doxorubicin, WP 697, Pidorubicin, UNII-3Z8479ZZ5X, CCRIS 2261, HSDB 6962, NSC 256942, BRN 1445813, 4'-epi-DX, CHEBI:47898, AOJJSUZBOXZQNB-VTZDEGQISA-N, 3Z8479ZZ5X, 4'-Epi-DXR, Pharmorubicin Pfs, (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside, (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, Epirubicin (INN), Farmorubicin (TN), NSC256942, NSC-256942, Acid, 8, AC1Q6JIV, CHEMBL417, AC1L26NP, SCHEMBL8582, DTXSID0022987, EPIRUBICIN(Hydrochloride form), BDBM43839, CTK8F9465, Doxorubicin-13CD3 (discontinued), ZINC3938704, AKOS027327569, CS-2824, DB00445, VA10821, NCGC00263918-04, (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside, (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione, 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, AK326115, AN-40147, HY-13624, LS-93992, SBI-0206890.P001, LS-187190, FT-0630692, A12409, C11230, D07901, 15206-EP2269994A1, 15206-EP2270008A1, 15206-EP2270018A1, 15206-EP2272827A1, 15206-EP2275420A1, 15206-EP2280012A2, 15206-EP2281815A1, 15206-EP2289892A1, 15206-EP2292615A1, 15206-EP2292617A1, 15206-EP2295055A2, 15206-EP2295416A2, 15206-EP2295426A1, 15206-EP2295427A1, 15206-EP2298748A2, 15206-EP2298764A1, 15206-EP2298765A1, 15206-EP2298768A1, 15206-EP2298778A1, 15206-EP2298780A1, 15206-EP2301928A1, 15206-EP2301933A1, 15206-EP2305640A2, 15206-EP2305642A2, 15206-EP2305671A1, 15206-EP2305689A1, 15206-EP2308855A1, 15206-EP2308861A1, 15206-EP2311453A1, 15206-EP2311808A1, 15206-EP2311825A1, 15206-EP2311827A1, 15206-EP2311829A1, 15206-EP2311840A1, 15206-EP2311842A2, 15206-EP2316832A1, 15206-EP2316833A1, AB00698552-11, AB00698552-13, AB00698552-14, AB00698552_15, AB00698552_16, A831042, BRD-K04548931-003-16-5, (7S,9S)-7-[(2R,4S,5R,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione, (7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione, (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione, 4'-Epidoxorubicin|||4'-Epiadriamycin|||(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-, 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-, doxorubicin, epirarubicin, farmarubicin, farmarubicine, pharmarubicin, Farmorubicina, Farmorubicine, Pharmorubicin, Epilem, Epirubicin HCl, EPIcell, Triferric doxorubicin, 4' Epiadriamycin, EPI cell, EPI-cell, Epirubicin (TN), Epirubicin hydrochloride, 4' Epidoxorubicin, 4'-epi-Adriamycin, Ellence (TN), 4' Epi Adriamycin, Pharmorubicin (TN), 4' Epi Doxorubicin, Ebewe (TN), Hydrochloride, Epirubicin, 4' Epi DXR, D0C9XJ, IMI-28, IMI28, C27H29NO11, CID41867, C27-H29-N-O11, ACN-038342, CS-O-01481, 2020B, D015251, 23214-92-8, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.beta.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, 56390-09-1, DM2, DM6,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited